IL-6 protein was significantly higher in pre-treatment plasma samples from RCC (IMmotion150) patients compared with healthy controls (Figure S1B) and correlated significantly with tumor IL6 mRNA (r = 0.32, p < 0.0001; Figure S1C). Here, IL6 is linked to neoplasm.